Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas
British Journal of Haematology · 2026-07 · 209 (1) · 31-41
DOI: 10.1111/bjh.70575 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 24.05.2026. Verfasst von Coura Fall und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Hematology, Hematological Genetics Unit, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Chromosome Aberrations, Chromosome Mapping. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research and Innovation Grenoble, Association pour la Recherche sur les Affections Malignes en Immunologie Sanguine (ARAMIS).
Abstract (Originalsprache)
Classical cytogenetics (CC) encompassing fluorescence in situ hybridisation (FISH) and karyotype remains central to the diagnostic work‐up of non‐Hodgkin lymphoma (NHL). However, karyotype is limited by restricted access to fresh tumour tissue and low resolution, while FISH provides targeted information. Optical genome mapping (OGM) has emerged as a genome‐wide, high‐resolution approach capable of detecting both translocations and copy number variations in a single assay. To assess its feasibility and diagnostic performance in routine practice, we prospectively compared OGM to CC in 105 patients with NHL. OGM was technically feasible in both fresh and frozen tissue specimens. Among 511 cytogenetic abnormalities (CAs) directly compared, 91.1% were concordant between the two methods. Using the low allele fraction guided assembly pipeline, OGM identified all 77 immunoglobulin loci rearrangements, with a sensitivity threshold of 5%. Overall, OGM detected diagnostically relevant CAs in 99/105 patients (94.2%). OGM outperformed CC in 10/105 patients (9.5%), revealing cryptic rearrangements involving major target genes ( MYC , BCL2 and BCL6 ) as well as diagnostically relevant CAs in cases with uncertain diagnoses or non‐informative karyotypes. In conclusion, OGM demonstrated feasibility in routine practice and superior diagnostic performance compared with CC, supporting its integration into the standard genetic work‐up of NHL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Hematology, Hematological Genetics Unit, Grenoble Alpes University Hospital, Grenoble, France.
- Institute of Medical Genetics, Lille University Hospital, Lille, France.
- Hematology and Immunology Laboratory, Valenciennes University Hospital, Valenciennes, France.
- Department of Pathology, Grenoble Alpes University Hospital, Grenoble, France.
- INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), University Grenoble Alpes, Grenoble, France.
- Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.
ORCID-Profile: Agnès Daudignon, Julie Mondet, Edouard Bonneville, Hélène Guermouche, Anouk Emadali, Christine Lefebvre
Förderung
- Health Research and Innovation Grenoble
- Association pour la Recherche sur les Affections Malignes en Immunologie Sanguine (ARAMIS)
Zitieren
APA
Fall, C., Daudignon, A., Valmary-Degano, S., Mondet, J., Bussot, L., Molina, L., Chevalier, S., Bonneville, E., Aubert, P., Tondeur, S., Legrand, C., Gaillard, J. B., Guermouche, H., Emadali, A., Carras, S., & Lefebvre, C. (2026). Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas. British Journal of Haematology, 209(1), 31-41. https://doi.org/10.1111/bjh.70575
Vancouver
Fall C, Daudignon A, Valmary-Degano S, Mondet J, Bussot L, Molina L, et al. Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas. British Journal of Haematology. 2026;209(1):31-41. doi:10.1111/bjh.70575
BibTeX
@article{Fall2026,
author = {Fall, Coura and Daudignon, Agnès and Valmary-Degano, Séverine and Mondet, Julie and Bussot, Lucile and Molina, Lysiane and Chevalier, Simon and Bonneville, Edouard and Aubert, Pierre and Tondeur, Sylvie and Legrand, Clémentine and Gaillard, Jean-Baptiste and Guermouche, Hélène and Emadali, Anouk and Carras, Sylvain and Lefebvre, Christine},
title = {Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {1},
pages = {31--41},
doi = {10.1111/bjh.70575}
}
EUVIMED